Brain Scientific files provisional US patent application for a new, long-term monitoring EEG cap

Brain Scientific files provisional US patent application for a new, long-term monitoring EEG cap

Proactive Investors

Published

Brain Scientific Inc (OTCQB:BRSF) announced Wednesday that it has filed a provisional US patent application for a new, long-term monitoring EEG cap.  “The new EEG product for which Brain Scientific is seeking a patent approval is a flexible head cap for conducting electroencephalography,” said Irina Nazarova, the company’s marketing director, in a statement. “The cap carries multiple dry electrodes that are placed at various positions corresponding to various channels for bio-signal collection." Brain Scientific said the new flexible full head EEG cap is a response to the market demand for size-adjustable EEG, with maximized electrode placement coverage and strong contact with the scalp, where the person’s comfort is maximized and bio-signals collected are of high quality. READ: Brain Scientific gains traction with two novel medical-grade EEG devices Currently, during EEG testing, electrodes are put to the person’s head by either a cap application or placement of each electrode -- which is time-consuming and requires a trained technician. Also, reusable caps and electrodes need cleaning and adding gel - a lengthy procedure that can also transmit germs.  As a result, both methods can lead to recording incorrect signals if the person moves during the test. Additionally, when an electrode cap is used for EEG, customizing it to fit users remains a challenge due to the various head sizes. Disposable EEG caps address this problem but they can only be provided with pre-set sizes. Traditionally, EEG tests have been useful in helping diagnose conditions relating to brain injuries, such as seizures, strokes, brain tumors, Alzheimer’s disease and certain psychoses. Recent studies show more than 80% of hospitalized COVID-19 patients have neurological symptoms, which could require EEG testing.  Brain Scientific estimates that about 5 million patients in US emergency departments and ICUs are subject to seizures and could benefit from routine EEG tests. The New York City-based company also noted that EEG systems have gone through evolution to become an integral part of modern applications, such as brain-computer interface for controlling electronic devices, neurofeedback activities, electronic sports (e-sports), health and wellness parameter collection, virtual and augmented reality, and sleep pattern evaluations. Contact the author: patrick@proactiveinvestors.com Follow him on Twitter @PatrickMGraham  

Full Article